The roles of experienced and internalized weight stigma in healthcare experiences: Perspectives of adults engaged in weight management across six countries | PLOS ONE
![Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology](https://www.thelancet.com/cms/asset/c709a625-668f-411d-ba24-4c875e24aefa/gr1a.jpg)
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology
![These ancient weights helped create Europe's first free market more than 3000 years ago | Science | AAAS These ancient weights helped create Europe's first free market more than 3000 years ago | Science | AAAS](https://www.science.org/do/10.1126/science.abk2007/abs/Bronze_age_euro_1280x720.jpg)
These ancient weights helped create Europe's first free market more than 3000 years ago | Science | AAAS
![How UK doctor linked rare blood-clotting to AstraZeneca Covid jab | Vaccines and immunisation | The Guardian How UK doctor linked rare blood-clotting to AstraZeneca Covid jab | Vaccines and immunisation | The Guardian](https://i.guim.co.uk/img/media/5eeef1aaf238221911446a78e9119b674d8cfde2/0_448_6720_4032/master/6720.jpg?width=1200&quality=85&auto=format&fit=max&s=83932d8ebc7420ccf69e42c5b7f712cd)
How UK doctor linked rare blood-clotting to AstraZeneca Covid jab | Vaccines and immunisation | The Guardian
![Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study - The Lancet Regional Health – Europe Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/asset/f6375fa3-6602-403b-a39c-ab43e4eded78/gr1.jpg)
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study - The Lancet Regional Health – Europe
![Lives versus Livelihoods? Perceived economic risk has a stronger association with support for COVID-19 preventive measures than perceived health risk | Scientific Reports Lives versus Livelihoods? Perceived economic risk has a stronger association with support for COVID-19 preventive measures than perceived health risk | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-88314-4/MediaObjects/41598_2021_88314_Fig1_HTML.png)